EGFR Channel News Network: On Location at ILCC 2026 with Dr. Deborah Doroshow and Dr. Amin Nassar

July 31, 2026

Dr. Debra Doroshow and Dr. Amin Nassar discuss combination therapy and treatment selection in high-risk, frontline EGFR-mutant NSCLC, including strategies for managing adverse events on the Conference floor of ILCC 2026.